VIVO 2

VIVO is intended for acquisition, analysis, display and storage of cardiac electrophysiological data and maps for analysis by a physician. VIVO is intended to be used as a pre-procedure planning tool for patients with structurally normal hearts undergoing ablation treatment for idiopathic ventricular arrhythmias. In clinical trials, VIVO was shown to be 100% (95% CI: 93.6%, 100% ) accurate in identifying a PVC or VT foci in the right, left, or septal region of the heart.

REPRESENTATIVE

Alexander de Vries

Director Commercial Operations
info@angiocare.nl